LAMPERT MARK N
Transactions
50
Companies
11
Filings
1
CIK
0001233840
Recent Transactions
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Award
- Award
- Award
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Award
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Disposition to Issuer
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Award
- Award
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Award
- Disposition to Issuer
- Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+201,546→ 201,546 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+156,742→ 156,742 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+156,742→ 156,742 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+201,546→ 201,546 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+201,546→ 201,546 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+156,742→ 156,742 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+201,546→ 201,546 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+201,546→ 201,546 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+156,742→ 156,742 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+156,742→ 156,742 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+156,742→ 156,742 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+201,546→ 201,546 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+201,546→ 201,546 total - Purchase
Pre-Funded Warrants to Purchase Common Stock
2024-08-20$40.75/sh+156,742→ 156,742 total
Companies
11- $FDMT
4D Molecular Therapeutics, Inc.
10% Owner
ARENA PHARMACEUTICALS INC
Director, 10% Owner
- $CAPS
Capstone Holding Corp.
10% Owner
- $CYTK
CYTOKINETICS INC
10% Owner
- $DVAX
DYNAVAX TECHNOLOGIES CORP
10% Owner
INFINITY PHARMACEUTICALS, INC.
10% Owner
- $KYMR
Kymera Therapeutics, Inc.
Director, See Remarks and Footnotes
- $NBIX
NEUROCRINE BIOSCIENCES INC
10% Owner
- $OLMA
Olema Pharmaceuticals, Inc.
Director, See Explanation of Responses
- $RPTX
Repare Therapeutics Inc.
10% Owner
Tobira Therapeutics, Inc.
10% Owner
Recent Filings
1Address
44 MONTGOMERY STREET 40TH FLOOR
SAN FRANCISCO, CA, 94104